Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H12AsNO5S2 |
| Molecular Weight | 377.268 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1=CC=C(C=C1)[As](SCC(O)=O)SCC(O)=O
InChI
InChIKey=YBQWEUNEYYXYOI-UHFFFAOYSA-N
InChI=1S/C11H12AsNO5S2/c13-11(18)7-1-3-8(4-2-7)12(19-5-9(14)15)20-6-10(16)17/h1-4H,5-6H2,(H2,13,18)(H,14,15)(H,16,17)
| Molecular Formula | C11H12AsNO5S2 |
| Molecular Weight | 377.268 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Thiacetarsamide is a drug containing trivalent arsenic. In the USA it was used for the treatment of Heartworm Infection in dogs and cats under tradename Caparsolate, however, it was discontinued because of the availability of safer alternatives. The mechanism of action for thiacetarsamide is modulation of glucose uptake and metabolism; inhibition of glutathione reductase, and alteration of the structure and function of the surface of the intestinal epithelium of the parasites.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:07:57 GMT 2025
by
admin
on
Mon Mar 31 18:07:57 GMT 2025
|
| Record UNII |
VMF4ELY9TZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
||
|
WHO-VATC |
QP52AX08
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
D001148
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
PRIMARY | |||
|
10749
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
PRIMARY | |||
|
DTXSID10201182
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
PRIMARY | |||
|
C66595
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
PRIMARY | |||
|
ARSENAMIDE
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
PRIMARY | |||
|
VMF4ELY9TZ
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
PRIMARY | |||
|
531-72-6
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
PRIMARY | |||
|
m10711
Created by
admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |